Search - tctmd.com

Displaying 781 - 800 of 1038

Sort: Relevancy | Date

News Industry News

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

August 24, 2012

News Daily News

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

Jason Kahn

August 24, 2012

News Daily News

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Yael L. Maxwell

August 23, 2012

News Daily News

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

August 14, 2012

News Daily News

Radiation-Free Right Heart Catheterization Feasible, Safe with MRI Guidance

L.A. McKeown

August 14, 2012

News Daily News

Small Study Supports Safety of Radial PCI in STEMI Patients

L.A. McKeown

August 07, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

Meta Análisis: El Balón Recubierto de Paclitaxel Reduce la RLD en la Enfermedad Femoropoplítea

August 07, 2012

News Industry News

Abbott's Omnilink Elite® Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

August 07, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Access Site Complications Often Related to Closure Failure in TAVR Procedures

Caitlin E. Cox

July 30, 2012

News Industry News

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

July 16, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 10, 2012

News Features

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 09, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Caitlin E. Cox

June 28, 2012

News Daily News

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

Caitlin E. Cox

June 21, 2012

News Industry News

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

June 21, 2012

Advertisement

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

Radiation-Free Right Heart Catheterization Feasible, Safe with MRI Guidance

Small Study Supports Safety of Radial PCI in STEMI Patients

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Meta Análisis: El Balón Recubierto de Paclitaxel Reduce la RLD en la Enfermedad Femoropoplítea

Abbott's Omnilink Elite® Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Access Site Complications Often Related to Closure Failure in TAVR Procedures

Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis for at least 9 months in 10 patients treated for peripheral

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Shift in CMS Policy Shines Spotlight on PCI Readmissions

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

More Than Half of Readmissions Within 30 Days of Acute MI Unrelated to Index Event

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content